Research Presentation Session

RPS 505 - AI in oncology

Lectures

1
RPS 505 - Spatio temporal risk prediction of focal bone lesion evolution in multiple myeloma

RPS 505 - Spatio temporal risk prediction of focal bone lesion evolution in multiple myeloma

04:52R. Licandro, Vienna / Austria

2
RPS 505 - A multi-institutional comparative effectiveness analysis of AI-assisted vs. current practice methods for advanced cancer imaging evaluation

RPS 505 - A multi-institutional comparative effectiveness analysis of AI-assisted vs. current practice methods for advanced cancer imaging evaluation

05:09A. Smith, Birmingham / United States

3
RPS 505 - Machine learning models applied to whole-body MRI in the staging of cancer: the MALIBO study

RPS 505 - Machine learning models applied to whole-body MRI in the staging of cancer: the MALIBO study

03:48A. Fagan, London/ UK

4
RPS 505 - Magnetic resonance imaging (MRI) radiomic features to predict tumour aggressiveness and outcomes in patients with endometrial cancer (EC)

RPS 505 - Magnetic resonance imaging (MRI) radiomic features to predict tumour aggressiveness and outcomes in patients with endometrial cancer (EC)

05:33J. Russell, London / UK

5
RPS 505 - Differentiating between invasive and non-invasive breast carcinomas in digital breast tomosynthesis using deep convolutional neural networks

RPS 505 - Differentiating between invasive and non-invasive breast carcinomas in digital breast tomosynthesis using deep convolutional neural networks

04:33D. Shimokawa, Sendai / Japan

6
RPS 505 - Differentiation of solid renal masses based on radiomic features from contrast-enhanced CT scan: a retrospective study

RPS 505 - Differentiation of solid renal masses based on radiomic features from contrast-enhanced CT scan: a retrospective study

05:48M. Aineseder, Buenos Aires / Argentina

7
RPS 505 - Advanced deep learning approach to automatically segment malignant tumours and ablation zone in liver with contrast-enhanced CT

RPS 505 - Advanced deep learning approach to automatically segment malignant tumours and ablation zone in liver with contrast-enhanced CT

04:50R. Shahzad, Cologne / Germany

8
RPS 505 - Incorporation of polymorphisms of SULF1 into a pre-treatment CT based machine-learning radiomic model to predict the risk of platinum resistance in ovarian cancer

RPS 505 - Incorporation of polymorphisms of SULF1 into a pre-treatment CT based machine-learning radiomic model to predict the risk of platinum resistance in ovarian cancer

04:34X. Yi, Changsha / China

9
RPS 505 - An MRI radiomics signature to distinguish benign from malignant orbital lesions

RPS 505 - An MRI radiomics signature to distinguish benign from malignant orbital lesions

05:06L. Duron, Paris / France

PEP Subscription Required

This course is only accessible for ESR Premium Education Package subscribers.